These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 30696458)

  • 1. Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy.
    Walsh R; Mazzarotto F; Whiffin N; Buchan R; Midwinter W; Wilk A; Li N; Felkin L; Ingold N; Govind R; Ahmad M; Mazaika E; Allouba M; Zhang X; de Marvao A; Day SM; Ashley E; Colan SD; Michels M; Pereira AC; Jacoby D; Ho CY; Thomson KL; Watkins H; Barton PJR; Olivotto I; Cook SA; Ware JS
    Genome Med; 2019 Jan; 11(1):5. PubMed ID: 30696458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing?
    Mazzarotto F; Olivotto I; Boschi B; Girolami F; Poggesi C; Barton PJR; Walsh R
    J Am Heart Assoc; 2020 Apr; 9(8):e015473. PubMed ID: 32306808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Utility of a Phenotype-Enhanced
    Mattivi CL; Bos JM; Bagnall RD; Nowak N; Giudicessi JR; Ommen SR; Semsarian C; Ackerman MJ
    Circ Genom Precis Med; 2020 Oct; 13(5):453-459. PubMed ID: 32894683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Testing in Patients with Hypertrophic Cardiomyopathy.
    Bonaventura J; Polakova E; Vejtasova V; Veselka J
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First identification of homozygous truncating CSRP3 variants in two unrelated cases with hypertrophic cardiomyopathy.
    Janin A; Bessière F; Chauveau S; Chevalier P; Millat G
    Gene; 2018 Nov; 676():110-116. PubMed ID: 30012424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Testing Yield and Clinical Characteristics of Hypertrophic Cardiomyopathy in Understudied Ethnic Groups: Insights From a New Zealand National Registry.
    Earle NJ; Winbo A; Crawford J; Wheeler M; Stiles R; Donoghue T; Stiles MK; Hayes I; Marcondes L; Martin A; Skinner JR
    Circ Heart Fail; 2024 Mar; 17(3):e010970. PubMed ID: 38456273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic yield of genetic testing in a heterogeneous cohort of 1376 HCM patients.
    Hathaway J; Heliö K; Saarinen I; Tallila J; Seppälä EH; Tuupanen S; Turpeinen H; Kangas-Kontio T; Schleit J; Tommiska J; Kytölä V; Valori M; Muona M; Sistonen J; Gentile M; Salmenperä P; Myllykangas S; Paananen J; Alastalo TP; Heliö T; Koskenvuo J
    BMC Cardiovasc Disord; 2021 Mar; 21(1):126. PubMed ID: 33673806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
    Amendola LM; Jarvik GP; Leo MC; McLaughlin HM; Akkari Y; Amaral MD; Berg JS; Biswas S; Bowling KM; Conlin LK; Cooper GM; Dorschner MO; Dulik MC; Ghazani AA; Ghosh R; Green RC; Hart R; Horton C; Johnston JJ; Lebo MS; Milosavljevic A; Ou J; Pak CM; Patel RY; Punj S; Richards CS; Salama J; Strande NT; Yang Y; Plon SE; Biesecker LG; Rehm HL
    Am J Hum Genet; 2016 Jun; 98(6):1067-1076. PubMed ID: 27181684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Testing in Hypertrophic Cardiomyopathy.
    Ireland CG; Ho CY
    Am J Cardiol; 2024 Feb; 212S():S4-S13. PubMed ID: 38368035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minor hypertrophic cardiomyopathy genes, major insights into the genetics of cardiomyopathies.
    Walsh R; Offerhaus JA; Tadros R; Bezzina CR
    Nat Rev Cardiol; 2022 Mar; 19(3):151-167. PubMed ID: 34526680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of 51 proposed hypertrophic cardiomyopathy genes from genome sequencing data in sarcomere negative cases has negligible diagnostic yield.
    Thomson KL; Ormondroyd E; Harper AR; Dent T; McGuire K; Baksi J; Blair E; Brennan P; Buchan R; Bueser T; Campbell C; Carr-White G; Cook S; Daniels M; Deevi SVV; Goodship J; Hayesmoore JBG; Henderson A; Lamb T; Prasad S; Rayner-Matthews P; Robert L; Sneddon L; Stark H; Walsh R; Ware JS; Farrall M; Watkins HC;
    Genet Med; 2019 Jul; 21(7):1576-1584. PubMed ID: 30531895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy.
    Filatova EV; Krylova NS; Vlasov IN; Maslova MS; Poteshkina NG; Slominsky PA; Shadrina MI
    Mol Genet Genomic Med; 2021 Nov; 9(11):e1808. PubMed ID: 34598319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare and Common Genetic Variation Underlying the Risk of Hypertrophic Cardiomyopathy in a National Biobank.
    Biddinger KJ; Jurgens SJ; Maamari D; Gaziano L; Choi SH; Morrill VN; Halford JL; Khera AV; Lubitz SA; Ellinor PT; Aragam KG
    JAMA Cardiol; 2022 Jul; 7(7):715-722. PubMed ID: 35583889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy.
    Bagnall RD; Ingles J; Dinger ME; Cowley MJ; Ross SB; Minoche AE; Lal S; Turner C; Colley A; Rajagopalan S; Berman Y; Ronan A; Fatkin D; Semsarian C
    J Am Coll Cardiol; 2018 Jul; 72(4):419-429. PubMed ID: 30025578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variant Interpretation for Dilated Cardiomyopathy: Refinement of the American College of Medical Genetics and Genomics/ClinGen Guidelines for the DCM Precision Medicine Study.
    Morales A; Kinnamon DD; Jordan E; Platt J; Vatta M; Dorschner MO; Starkey CA; Mead JO; Ai T; Burke W; Gastier-Foster J; Jarvik GP; Rehm HL; Nickerson DA; Hershberger RE; ;
    Circ Genom Precis Med; 2020 Apr; 13(2):e002480. PubMed ID: 32160020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls.
    Walsh R; Lahrouchi N; Tadros R; Kyndt F; Glinge C; Postema PG; Amin AS; Nannenberg EA; Ware JS; Whiffin N; Mazzarotto F; Škorić-Milosavljević D; Krijger C; Arbelo E; Babuty D; Barajas-Martinez H; Beckmann BM; Bézieau S; Bos JM; Breckpot J; Campuzano O; Castelletti S; Celen C; Clauss S; Corveleyn A; Crotti L; Dagradi F; de Asmundis C; Denjoy I; Dittmann S; Ellinor PT; Ortuño CG; Giustetto C; Gourraud JB; Hazeki D; Horie M; Ishikawa T; Itoh H; Kaneko Y; Kanters JK; Kimoto H; Kotta MC; Krapels IPC; Kurabayashi M; Lazarte J; Leenhardt A; Loeys BL; Lundin C; Makiyama T; Mansourati J; Martins RP; Mazzanti A; Mörner S; Napolitano C; Ohkubo K; Papadakis M; Rudic B; Molina MS; Sacher F; Sahin H; Sarquella-Brugada G; Sebastiano R; Sharma S; Sheppard MN; Shimamoto K; Shoemaker MB; Stallmeyer B; Steinfurt J; Tanaka Y; Tester DJ; Usuda K; van der Zwaag PA; Van Dooren S; Van Laer L; Winbo A; Winkel BG; Yamagata K; Zumhagen S; Volders PGA; Lubitz SA; Antzelevitch C; Platonov PG; Odening KE; Roden DM; Roberts JD; Skinner JR; Tfelt-Hansen J; van den Berg MP; Olesen MS; Lambiase PD; Borggrefe M; Hayashi K; Rydberg A; Nakajima T; Yoshinaga M; Saenen JB; Kääb S; Brugada P; Robyns T; Giachino DF; Ackerman MJ; Brugada R; Brugada J; Gimeno JR; Hasdemir C; Guicheney P; Priori SG; Schulze-Bahr E; Makita N; Schwartz PJ; Shimizu W; Aiba T; Schott JJ; Redon R; Ohno S; Probst V; ; Behr ER; Barc J; Bezzina CR
    Genet Med; 2021 Jan; 23(1):47-58. PubMed ID: 32893267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center.
    Mazzarotto F; Girolami F; Boschi B; Barlocco F; Tomberli A; Baldini K; Coppini R; Tanini I; Bardi S; Contini E; Cecchi F; Pelo E; Cook SA; Cerbai E; Poggesi C; Torricelli F; Walsh R; Olivotto I
    Genet Med; 2019 Feb; 21(2):284-292. PubMed ID: 29875424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal-to-Noise Analysis Can Inform the Likelihood That Incidentally Identified Variants in Sarcomeric Genes Are Associated with Pediatric Cardiomyopathy.
    Kurzlechner LM; Jones EG; Berkman AM; Tadros HJ; Rosenfeld JA; Yang Y; Tunuguntla H; Allen HD; Kim JJ; Landstrom AP
    J Pers Med; 2022 Apr; 12(5):. PubMed ID: 35629155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy Patients.
    Cirino AL; Lakdawala NK; McDonough B; Conner L; Adler D; Weinfeld M; O'Gara P; Rehm HL; Machini K; Lebo M; Blout C; Green RC; MacRae CA; Seidman CE; Ho CY;
    Circ Cardiovasc Genet; 2017 Oct; 10(5):. PubMed ID: 29030401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data-driven modelling of mutational hotspots and in silico predictors in hypertrophic cardiomyopathy.
    Waring A; Harper A; Salatino S; Kramer C; Neubauer S; Thomson K; Watkins H; Farrall M
    J Med Genet; 2021 Aug; 58(8):556-564. PubMed ID: 32732227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.